Inside WeightWatchers's fight to survive the Ozempic era
Briefly

Sima Sistani's journey with WeightWatchers mirrors that of many customers, showcasing the effectiveness of the company's points system when combined with personal resilience.
The focus for Sistani as CEO is to navigate WeightWatchers through a pivotal shift towards creating a robust digital community amidst rising competition in the weight-loss industry.
With the sudden drug shortages of Wegovy and Ozempic, Sistani faces unique challenges that could redefine the weight-loss market and WeightWatchers' role within it.
Sistani's leadership is not just about adapting to digital trends, but also about understanding the changing dynamics of weight-loss solutions in a post-pandemic world.
Read at Fast Company
[
|
]